drugset / Trial / NCT05786378
Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
NaSingle-groupOpen-labelTreatment
Summary
Assessment of the efficacy of Intratympanic platelet rich plasma injection for treatment of idiopathic suden sensorineural hearing loss
Timeline
- Start
- 2023-06-01
- Primary completion
- 2024-01
- Completion
- 2024-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | 0.5 ml | Intrathecal |
| Subject | Platelet Rich Plasma | Other / unclassified | 1 ml | Intrathecal |
| Background | Lidocaine | Other / unclassified | — | Topical |